The 340B Showdown: HRSA Proceeds Towards Enforcement Despite Litigation
FDA Law Blog
SEPTEMBER 29, 2021
Department of Health and Human Services (“HHS”), which reported that discounted purchases totaled $38 billion in 2020, a 27% increase compared to 2019. Manufacturers may choose not to participate in this program, but the federal government will not reimburse for their outpatient drugs under Medicaid or Medicare Part B if they do not.
52 
Let's personalize your content